4.5 Article

Aptamer-based diagnosis of various SARS-CoV2 strains isolated from clinical specimens

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study

Haidar Saify Nabiabad et al.

Summary: The study utilized aptamer-functionalized lipid nanoparticles (LNPs) to deliver RNAi molecules for treating SARS-CoV-2 infection, showing promising results. The aptamer in the nanocarrier serves two crucial functions - delivering the drug to the cell surface and inhibiting virus entry by binding to the virus.

CHEMICAL BIOLOGY & DRUG DESIGN (2022)

Article Virology

Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses

Anbalagan Anantharaj et al.

Summary: Over 90% of COVID-19 patients exhibit mild/moderate symptoms or are asymptomatic. This study collected samples from 23 hospitalized patients with mild symptoms and found that most mild infections are associated with an absence of inflammation and an active innate immune response, T-cell activation, and neutralizing antibodies.

JOURNAL OF CLINICAL VIROLOGY (2022)

Article Biophysics

Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrode-aptamer-SARS-CoV-2 imaging by photo-induced force microscopy

Juan Carlos Abrego-Martinez et al.

Summary: Quick and accurate diagnosis of the COVID-19 is crucial in stopping the spread of the virus. The development of an aptamer-based biosensor on a screen-printed carbon electrode platform shows promise in providing rapid and sensitive detection of SARS-CoV-2, offering a potential solution to the current challenges in COVID-19 diagnosis.

BIOSENSORS & BIOELECTRONICS (2022)

Editorial Material Chemistry, Multidisciplinary

A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS-CoV-2 Variants of Concern

[Anonymous]

Summary: The cover of this issue features the research team at McMaster University, led by John Brennan and Yingfu Li, who have discovered a universal DNA aptamer that recognizes spike proteins of various SARS-CoV-2 variants.

CHEMISTRY-A EUROPEAN JOURNAL (2022)

Article Multidisciplinary Sciences

Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants

Clauber Henrique Souza da Costa et al.

Summary: This study systematically analyzed the binding between the Spike protein receptor-binding domain (RBD) and the human angiotensin-converting enzyme 2 (ACE2) receptor of the SARS-CoV-2 Omicron variant and other variants using simulations and calculations. The results showed that the binding between Omicron and ACE2 is stronger than other variants, and certain mutations stabilize this interaction. The findings suggest that the faster spread of SARS-CoV-2 Omicron may be associated with the binding affinity of the Spike protein RBD to ACE2 and mutations of uncharged residues to positively charged residues in key positions of the RBD.

SCIENTIFIC REPORTS (2022)

Article Mathematics, Applied

Dynamics and bifurcations of a discrete-time Lotka-Volterra model using nonstandard finite difference discretization method

Zohreh Eskandari et al.

Summary: A newly disclosed nonstandard finite difference method was used to discretize a prey-predator model, and the critical normal form coefficients of bifurcations for both one-parameter and two-parameter bifurcations were investigated. The model exhibited various local bifurcations such as period-doubling, Neimark-Sacker, and strong resonances. The analysis of critical normal form coefficients revealed the dynamical scenarios corresponding to each bifurcation point. Numerical simulations using Matlab package validated the theoretical analysis and provided ecological insights.

MATHEMATICAL METHODS IN THE APPLIED SCIENCES (2022)

Article Chemistry, Multidisciplinary

Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection

Xiaohui Liu et al.

Summary: The receptor-binding domain of the SARS-CoV-2 spike protein is crucial for mediating virus entry into human cells, making it an ideal target for blocking infection. Using aptamers specifically targeting the S/RBD, researchers were able to effectively prevent virus binding to host cells and neutralize viral particles expressing the S protein, demonstrating a promising COVID-19 therapeutic strategy.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Chemistry, Multidisciplinary

A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism**

Anton Schmitz et al.

Summary: A specific aptamer that interacts with the coronavirus SARS-CoV-2 has been identified, showing potent and specific inhibition of pseudoviral infection despite not blocking the virus's interaction with ACE2. This study opens new avenues for developing inhibitors of SARS-CoV-2 infection and highlights the potential of aptamers as drug candidates and tools for unraveling previously inaccessible infection modalities.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Chemistry, Multidisciplinary

Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection

Miao Sun et al.

Summary: The research strategy focused on blocking SARS-CoV-2 infection through aptamer selection, identifying and applying the high-affinity aptamer CoV2-6, further engineered into the circular bivalent aptamer cb-CoV2-6C3 to enhance stability and inhibition efficacy.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Multidisciplinary Sciences

A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry

Julian Valero et al.

Summary: A special RNA aptamer with high affinity to the receptor binding domain of SARS-CoV-2 spike protein has been discovered, preventing its interaction with the host receptor and efficiently blocking viral infection. Trimerized version of the aptamer enhances binding affinity, showing potential for widespread use in detecting and treating SARS-CoV-2 and emerging variants.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Virology

Xeno-Nucleic Acid (XNA) 2'-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding

Irani Alves Ferreira-Bravo et al.

Summary: Aptamers generated using SELEX method with FANA show high affinity to RBD and S1 domains of SARS-CoV-2, directly blocking their interaction with ACE2, exhibiting high specificity and affinity similar to previous DNA aptamers.

VIRUSES-BASEL (2021)

Article Medicine, Research & Experimental

A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2

Ankit Gupta et al.

Summary: The study identified a DNA aptamer with strong binding ability to the spike trimer antigen of SARS-CoV-2 using Systematic Evolution of Ligands by EXponential enrichment. The aptamer, named S14, showed high affinity and structure, capable of detecting antigens as low as 2 nM. Clinical evaluation demonstrated its highly discriminatory performance in differentiating between SARS-CoV-2 infected and non-infected individuals.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Immunology

Development of Inactivated FAKHRAVAC(R) Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models

Soheil Ghasemi et al.

Summary: This study evaluated the potency and safety of an inactivated SARS-CoV-2 vaccine candidate (FAKHRAVAC) in a preclinical study, showing that this vaccine candidate induced neutralizing antibodies in various animal models and achieved a 100% seroconversion rate in tested animals after 28 days of immunization. These results support further evaluation of FAKHRAVAC in clinical trials.

VACCINES (2021)

Article Chemistry, Multidisciplinary

Discovery and Characterization of Spike N-Terminal Domain-Binding Aptamers for Rapid SARS-CoV-2 Detection

Nataly Kacherovsky et al.

Summary: The COVID-19 pandemic has caused devastation to families, healthcare, economies, and societies globally. Molecular recognition agents that bind to specific viral proteins are crucial for rapid diagnostics and targeted therapeutics. This work demonstrates the selection of novel DNA aptamers that bind to the SARS-CoV-2 spike glycoprotein with high specificity and affinity, making them promising tools for COVID-19 diagnostics.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Biochemistry & Molecular Biology

Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library

Jiuxing Li et al.

Summary: In vitro selection experiments identified DNA aptamers, MSA1 and MSA5, with strong binding affinity to the S1 subunit of the SARS-CoV-2 spike protein. These aptamers demonstrated comparable affinities for various forms of S1 protein and also recognized the pseudotyped lentivirus of SARS-CoV-2, highlighting their potential as diagnostic tools for COVID-19 detection. The development of a colorimetric sandwich assay using MSA1 further confirmed the utility of these aptamers in detecting the virus in saliva samples.

NUCLEIC ACIDS RESEARCH (2021)

Article Multidisciplinary Sciences

Aptamer based diagnosis of crimean-congo hemorrhagic fever from clinical specimens

Tahmineh Jalali et al.

Summary: Crimean-Congo hemorrhagic fever is an acute viral zoonotic disease that requires rapid diagnosis for effective patient management. Aptamers, specifically Apt33, have been successfully used in ELASA tests to detect CCHF NP with high specificity and sensitivity, showing potential as a rapid diagnostic tool for CCHF virus infection.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors

Ana S. Peinetti et al.

Summary: A new method has been developed for direct detection and differentiation of infectious viruses, including human adenovirus and SARS-CoV-2, from noninfectious ones without the need for sample pretreatment. This method utilizes DNA aptamers to bind intact infectious viruses and incorporates them into a solid-state nanopore for enhanced sensitivity. Applications of this sensor have been demonstrated in various types of samples, making it generally applicable for detecting emerging viruses of environmental and public health concern.

SCIENCE ADVANCES (2021)

Review Biochemical Research Methods

Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics

Yi Zhong et al.

ANALYTICAL BIOCHEMISTRY (2020)

Review Oncology

Coronavirus disease 2019 (COVID-19): a clinical update

Min Zhou et al.

FRONTIERS OF MEDICINE (2020)

Article Chemistry, Analytical

Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein

Yanling Song et al.

ANALYTICAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

Antonio E. Muruato et al.

NATURE COMMUNICATIONS (2020)